PATH vs STIM
Uipath Inc (PATH) versus Neuronetics Inc (STIM) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Neuronetics Inc (STIM) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported STIM revenue for 2024-12-31 was $74.9M. Net income was -$43.7M. Revenue was up 5.0% from 2023-12-31 to 2024-12-31. STIM currently screens at market cap $84.2M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. STIM currently screens at market cap $84.2M.
Not investment advice. Open the PATH and STIM stock pages for the full models.
Not investment advice.